Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Iterum Therapeutics plc as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +7 vs. Q3 2024
- Shares held
- 1.23M
- −808.7K (−39.6%) vs. Q3 2024
- Total value
- $2.18M
- −$48.5K (−2.2%) vs. Q3 2024
- New holders
- 12
- 3 more added
- Sold out
- 5
- 1 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $542 |
| Q1 2026 | 18 | $41.3K |
| Q4 2025 | 20 | $557.9K |
| Q3 2025 | 24 | $904.1K |
| Q2 2025 | 24 | $2.38M |
| Q1 2025 | 20 | $1.38M |
| Q4 2024 | 24 | $2.18M |
| Q3 2024 | 18 | $2.22M |
| Q2 2024 | 15 | $494.7K |
| Q1 2024 | 18 | $1.43M |
| Q4 2023 | 16 | $761.6K |
| Q3 2023 | 15 | $184.0K |
| Q2 2023 | 17 | $393.4K |
| Q1 2023 | 17 | $187.3K |
| Q4 2022 | 23 | $243.7K |
| Q3 2022 | 25 | $575.4K |
| Q2 2022 | 39 | $1.18M |
| Q1 2022 | 41 | $1.80M |
| Q4 2021 | 45 | $2.57M |
| Q3 2021 | 42 | $3.45M |
| Q2 2021 | 45 | $26.0M |
| Q1 2021 | 50 | $11.2M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Iterum Therapeutics plc; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 438,816 | $776.7K | 0.00% | +438,816 | New |
| New Leaf Venture Partners, L.L.C. | 345,020 | $610.7K | 0.82% | 00.0% | Unchanged |
| Apollon Financial, LLC | 250,250 | $442.9K | 0.11% | +25,500+11.3% | Added |
| Creative Financial Designs Inc | 59,900 | $106.0K | 0.01% | +59,900 | New |
| Two Sigma Investments, LP | 25,245 | $44.7K | 0.00% | +25,245 | New |
| Citadel Advisors LLC | 21,207 | $37.5K | 0.00% | +21,207 | New |
| Sanctuary Advisors, LLC | 20,000 | $31.4K | 0.00% | +20,000 | New |
| Lee Financial Co | 16,000 | $28.3K | 0.00% | +16,000 | New |
| Alpine Global Management, LLC | 15,000 | $26.6K | 0.01% | −49,833−76.9% | Reduced |
| Geode Capital Management, LLC | 12,370 | $21.9K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 11,729 | $20.8K | 0.00% | +6,250+114.1% | Added |
| Jane Street Group, LLC | 10,262 | $18.2K | 0.00% | +10,262 | New |
| UBS Group AG | 3,074 | $5.44K | 0.00% | +3,073+307,300.0% | Added |
| Medallion Wealth Advisors, LLC | 1,680 | $2.07K | 0.00% | +1,680 | New |
| Tower Research Capital LLC (TRC) | 710 | $1.26K | 0.00% | +710 | New |
| Barclays PLC | 500 | $885 | 0.00% | +500 | New |
| Activest Wealth Management | 133 | $235 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 85 | $150 | 0.00% | 00.0% | Unchanged |
| Blue Bell Private Wealth Management, LLC | 66 | $117 | 0.00% | 00.0% | Unchanged |
| Cypress Capital Management LLC (WY) | 66 | $117 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 15 | $27 | 0.00% | +15 | New |
| SBI Securities Co., Ltd. | 14 | $25 | 0.00% | +14 | New |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 13 | $23 | 0.00% | 00.0% | Unchanged |
| HM Payson & Co | 3 | $6 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −1,340,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −33,040−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,947−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Planning Capital Management Corp | – | – | – | – | Not filed |